Print Page  Close Window

News Release

Emergent BioSolutions to Host Conference Call on March 22, 2007 to Announce Fourth Quarter and Full Year 2006 Financial Results

ROCKVILLE, Md.--(BUSINESS WIRE)--March 15, 2007--Emergent BioSolutions Inc. (NYSE:EBS) announced today that it will report financial results for the fourth quarter and full year 2006 on Thursday, March 22, 2007, before market open.

Company management will host a conference call at 10:00 am ET on March 22, 2007 to discuss these financial results. The dial in numbers will be: domestic (866) 202-0886, international (617) 213-8841. To listen to a live webcast of the conference call, please go to the "Investors" link in the company website at www.emergentbiosolutions.com.

A replay of this call will be available from 12:00 pm ET on March 22, 2007 until close of business April 5, 2007 at the following numbers: domestic (888) 286-8010, international (617) 801-6888. The Passcode for access to the replays is 16852790. An archived webcast of the conference call will be available under the "Investors" section of the company's website at www.emergentbiosolutions.com.

The conference call, replay and webcast are open to all interested parties.

About Emergent BioSolutions Inc.

Emergent BioSolutions Inc. is a biopharmaceutical company focused on the development, manufacture and commercialization of immunobiotics, such as vaccines and therapeutics that induce or assist the body's immune system to prevent or treat disease. The company's biodefense business is focused on developing and commercializing immunobiotics for use against biological agents that are potential weapons of bioterrorism. The company's commercial business is focused on developing immunobiotics for use against infectious diseases which pose significant unmet or underserved public health needs. More information on the company is available at www.emergentbiosolutions.com.

CONTACT: Emergent BioSolutions Inc.
Robert G. Burrows, 301-795-1877
burrowsr@ebsi.com

SOURCE: Emergent BioSolutions Inc.